Europe Insulin Pens Market to Reach US$ 1,829.7 Mn at CAGR of 8.4% in 2027 | The Insight Partners

Europe Insulin Pens Market to 2027- Regional Analysis and Forecasts by Product Type (Disposable and Reusable); Application (Diabetes Type-1 and Diabetes Type-2); Distribution Channel (Hospital Pharmacies, Retail Pharmacies and e-Commerce) and Geography

Publication Month: Jul 2019 | Report Code: TIPRE00006289 | No. of Pages: 120 | Category: Medical Device | Status: Published

The Europe insulin pen market is expected to reach US$ 1,829.7 Mn in 2027 from US$ 900.8 Mn in 2018. The market is estimated to grow with a CAGR of 8.4% from 2019-2027.

 

The growth of the market is driven by the factors such as, growing geriatric population and rising incidence of diabetes. However, the market is likely to get impacted due to availability of alternatives for drug delivery and limitations associated with insulin pens in the region.

 

Diabetes among geriatric population is a growing public health burden worldwide. It is a major cause morbidity and mortality in ageing population that later largely attributable to various chronic complications. Ageing population is poised to become one of the most significant transformation with a heavy impact on the social and economic level across the Europe. According to a report of United Nation in 2017, there were approximately 183 million people aged 60 or above across the Europe in 2017 and was projected to reach to 247.2million by 2050. The number of geriatric population is expected to grow significantly in Europe, Diabetes has been growing as a major health problem and a significant burden on the population and on health systems of developing countries. There are about 60 million people with diabetes in the Europe, or about 10.3% of men and 9.6% of women aged 25 years and over. Prevalence of diabetes is increasing among all ages in the European Region, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity. The elderly people are more likely to have diabetes than younger people, and the effect of the disease on quality of life is particularly deep in this population. With increase in the number of geriatric population, the prevalence of the diabetes has increased. Therefore, the demand of insulin pens, which are devices that facilitate easy administration of insulin are expected to increase in the forecast period.

 

Germany is expected to lead the market in the Europe region owing to rising prevalence of the diabetes and support by the government in the country. In addition, the government in Germany are putting their efforts to improve the conditions for the people suffering from the diabetes. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period.

 

 

 

EUROPE DIABETES CARE DEVICES – MARKET SEGMENTATION

By Product

  • Disposable
  • Reusable

 

By End User

  • Diabetes Type-1
  • Diabetes Type-2

 

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

 

By Geography

  • Europe
    • US
    • Canada
    • Mexico

Company Profiles

  • Owen Mumford, LTD.
  • Novo Nordisk a/s
  • Companion Medical
  • Berlin-Chemie AG
  • Pendiq GmbH
  • Emperra GmbH E-Health Technologies
  • Eli lilly and company
  • Ypsomed Ag
  • SANOFI
  • Biocon

Part 1. Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

Part 2. North America Diabetes Care Devices Market – Key Takeaways

Part 3. North America Diabetes Care Devices Market – Market Landscape

3.1       overview

3.2       market segmentation

3.2.1       North America Diabetes Care Devices Market – By Product

3.2.2       North America Diabetes Care Devices Market – By End USer

3.2.3       North America Diabetes Care Devices Market – By Country

3.3       PEST Analysis

Part 4. North America Diabetes Care Devices Market - Key Market Dynamics

4.1       Key Market Drivers

4.1.1       Growing Geriatric Population

4.1.2       Rapid Technological Advancements in Diabetes Care Devices

4.2       Key Market Restraints

4.2.1       High Cost of Diabetes Care Devices

4.2.2       Risks Associated with the Insulin Delivery Devices

4.3       Key Market Opportunities

4.3.1       Development of Cost Efficient Pen Needles

4.4       future Trends

4.4.1       Growing Product Innovations

4.5       Impact analysis

Part 5. Diabetes Care Devices Market – North America Analysis

5.1       North America DIABETES CARE DEVICES market Revenue Forecasts and Analysis

5.2       Market positioning

5.3       PERFORMANCE OF KEY PLAYERS

5.3.1       Medtronic

5.3.2       F. Hoffmann-La Roche Ltd.

Part 6. North America Diabetes Care Devices Market Analysis – By Product

6.1       overview

6.2       North America diabetes care devices Market BY Product, 2018 & 2027 (%)

6.3       North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)

6.3.1       North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

6.3.2       North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

6.4       Glucose Monitoring Devices Market

6.4.1       Overview

6.4.2       North America Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.4.3       Glucometers Market

6.4.3.1    Overview

6.4.3.2    North America Glucometers Market Revenue and Forecast to 2027 (US$ Mn)

6.4.4       Lancets Market

6.4.4.1    Overview

6.4.4.2    North America Lancets Market Revenue and Forecast to 2027 (US$ Mn)

6.4.5       Testing Strips Market

6.4.5.1    Overview

6.4.5.2    North America Testing Strips Market Revenue and Forecast to 2027 (US$ Mn)

6.4.6       Other Glucose Monitoring Devices Market

6.4.6.1    Overview

6.4.6.2    North America Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.5       Insulin Delivery Devices Market

6.5.1       Overview

6.5.2       North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.5.3       Insulin Pens Market

6.5.3.1    Overview

6.5.3.2    North America Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn)

6.5.4       Insulin Syringes Market

6.5.4.1    Overview

6.5.4.2    North America Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn)

6.5.5       Insulin Pumps Market

6.5.5.1    Overview

6.5.5.2    North America Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn)

6.5.6       Other Insulin Delivery Devices Market

6.5.6.1    Overview

6.5.6.2    North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

Part 7. North America Diabetes Care Devices Market Analysis – By End USer

7.1       Overview

7.2       NORTH AMERICA DIABETES CARE DEVICES MARKET, BY End USer, 2018 & 2027 (%)

7.3       North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)

7.4       Homecare MArket

7.4.1       Overview

7.4.2       North America Homecare Market Revenue and Forecasts to 2027 (US$ Mn)

7.5       hospitals & Clinics Market

7.5.1       Overview

7.5.2       North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

Part 8. North America Diabetes Care Devices Market Revenue And Forecasts To 2027

8.1       Overview

8.2       North America DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)

8.3       North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.3.1       North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.2       North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4       North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)

8.5       North America Diabetes care devices Market Revenue And Forecasts to 2027, By Country (%)

8.6       US DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)

8.6.1       US Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.2       US Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.6.2.1    US Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.6.2.2    US Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.6.3       US Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

8.7       Canada Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.7.1       Canada Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.7.2       Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.7.2.1    Canada Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.7.2.2    Canada Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.7.3       Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

8.8       Mexico Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.8.1       Mexico Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.8.2       Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.8.2.1    Mexico Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.8.2.2    Mexico Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.8.3       Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

Part 9. Diabetes Care Devices Market – Industry Landscape

9.1       Overview

9.2       Comparative Company Analysis

9.3       Growth Strategies done by the companies in the Market, (%)

9.4       Organic Developments

9.4.1       Overview

9.5       Inorganic developments

9.5.1       Overview

Part 10. Diabetes Care Devices Market–Key Company Profiles

10.1    BD

10.1.1    Key Facts

10.1.2    Business Description

10.1.3    Financial Overview

10.1.4    Product Portfolio

10.1.5    SWOT Analysis

10.1.6    Key Developments

10.2    novo nordisk a/s

10.2.1    Key Facts

10.2.2    Business Description

10.2.3    Financial Overview

10.2.4    Product Portfolio

10.2.5    SWOT Analysis

10.2.6    Key Developments

10.3    B. Braun Melsungen AG

10.3.1    Key Facts

10.3.2    Business Description

10.3.3    Financial Overview

10.3.4    Product Portfolio

10.3.5    SWOT Analysis

10.3.6    Key Developments

10.4    Medtronic

10.4.1    Key Facts

10.4.2    Business Description

10.4.3    Financial Information

10.4.4    Product Portfolio

10.4.5    SWOT Analysis

10.4.6    Key Developments

10.5    Tandem Diabetes Care, Inc.

10.5.1    Key Facts

10.5.2    Business Description

10.5.3    Financial Information

10.5.4    Product Portfolio

10.5.5    SWOT Analysis

10.5.6    Key Developments

10.6    Insulet Corporation

10.6.1    Key Facts

10.6.2    Business Description

10.6.3    Financial Information

10.6.4    Product Portfolio

10.6.5    SWOT Analysis

10.6.6    Key Developments

10.7    Eli lilly and company

10.7.1    Key Facts

10.7.2    Business Description

10.7.3    Financial Overview

10.7.4    Product Portfolio

10.7.5    SWOT Analysis

10.7.6    Key Developments

10.8    Dexcom, Inc.

10.8.1    Key Facts

10.8.2    Business Description

10.8.3    Financial Overview

10.8.4    Product Portfolio

10.8.5    SWOT Analysis

10.8.6    Key Developments

10.9    Terumo Corporation

10.9.1    Key Facts

10.9.2    Business Description

10.9.3    Financial Overview

10.9.4    Product portfolio

10.9.5    SWOT ANALYSIS

10.9.6    KEY DEVELOPMENTS

10.10  F. Hoffmann-La Roche Ltd.

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Financial Overview

10.10.4 Product Portfolio

10.10.5 SWOT Analysis

10.10.6 Key Developments

Part 11. Appendix

11.1    About The Insight Partners

11.2    Glossary of Terms

11.3    Methodology

11.3.1    Coverage

11.3.2    Secondary Research

11.3.3    Primary Research

LIST OF TABLES

Table 1.            Total Number Of Persons Ofaged 60 Years Or Above By Region, 2017 & 2050

Table 2.            North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 3.            North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 4.            North America Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 5.            North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 6.            North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 7.            North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 8.            North America Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 9.            North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 10.         US Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 11.         US Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 12.         US Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 13.         US Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 14.         Canada Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 15.         Canada Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 16.         Canada Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 17.         Canada Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 18.         Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 19.         Mexico Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 20.         Mexico Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 21.         Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 22.         Organic Developments Done By Companies

Table 23.         Inorganic Developments Done By Companies

Table 24.         Glossary Of Terms, Diabetes Care Devices Market

LIST OF FIGURES

Figure 1.          US Diabetes Care Devices Market, Revenue (US$ Mn), By Country 2018 & 2027

Figure 2.          North America Diabetes Care Devices Market By Product, Market Share (%), 2018

Figure 3.          North America Diabetes Care Devices Market By End USer, Market Share (%), 2018

Figure 4.          Diabetes Care Devices Market Segmentation

Figure 5.          North America Pest Analysis

Figure 6.          Diabetes Care Devices Market Impact Analysis Of Drivers & Restraints

Figure 7.          North America Diabetes Care Devices Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 8.          North America Diabetes Care Devices Market, By Product 2018 & 2027 (%)

Figure 9.          North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 10.       North America Glucometers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 11.       North America Lancets Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12.       North America Testing Strips Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13.       North America Other Glucose Monitoring Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.       North America Insulin Delivery Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 15.       North America Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.       North America Insulin Syringes Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17.       North America Insulin Pumps Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 18.       North America Insulin Delivery Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       North America Diabetes Care Devices Market By End USer, 2018 & 2027 (%)

Figure 20.       North America Homecare Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 21.       North America Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.       North America Diabetes Care Devices Market Revenue Overview, By Country, 2018 (US$ Mn)

Figure 23.       North America Diabetes Care Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Country (%)

Figure 25.       US Diabetes Care Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26.       Canada Diabetes Care Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 27.       Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 28.       Comparative Company Analysis

Figure 29.       Growth Strategies Done By The Companies In The Market, (%)

The List of Companies

 

  1. Owen Mumford, LTD.
  2. Novo Nordisk a/s
  3. Companion Medical
  4. Berlin-Chemie AG
  5. Pendiq GmbH
  6. Emperra GmbH E-Health Technologies
  7. Eli lilly and company
  8. Ypsomed Ag
  9. SANOFI
  10. Biocon